Evidence map›Paper›PMID 35625467›Full record

ArticleBiology2022

D-Carvone Attenuates CCl

Hanan A Ogaly, Sharah A A Aldulmani, Fatimah A M Al-Zahrani, Reham M Abd-Elsalam

Abstract read
In one paragraph

Article in Biology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Neuroprotection byInternational journal of molecular sciences · 2024
    Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Hanan A OgalyDepartment of Chemistry, College of Science, King Khalid University, Abha 61421, Saudi Arabia.ORCID 0000-0002-0480-5127
Sharah A A AldulmaniDepartment of Chemistry, College of Science, King Khalid University, Abha 61421, Saudi Arabia.
Fatimah A M Al-ZahraniDepartment of Chemistry, College of Science, King Khalid University, Abha 61421, Saudi Arabia.
Reham M Abd-ElsalamDepartment of Pathology, Faculty of Veterinary Medicine, Cairo University, Giza 12211, Egypt.

Funding

Deanship of Scientific Research, King Khalid University, Abha, Saudi Arabia R.G.P.1/190/41
6 · The paper itself

Abstract

D-carvone is a natural monoterpene found in abundance in the essential oil of aromatic medicinal plants with a wide range of pharmacological values. However, the impact of D-carvone on liver fibrosis remains unclear. This study aimed to evaluate the anti-fibrotic potential of D-carvone in a rat model of liver fibrosis and to clarify the possible underlying mechanisms. Liver fibrosis was induced in rats by carbon tetrachloride, CCl

Indexed as

antioxidantD-carvonefibrosisMMP9TGF-β1/SMAD3α-SMA

Identifiers

PMID35625467
PMCPMC9138456

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.